González Lama Y, Marín-Jiménez I
Unidad EII, Servicio de Aparato Digestivo, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
Unidad EII, Servicio de Aparato Digestivo, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, España.
Actas Dermosifiliogr. 2016 Sep;107 Suppl 2:2-7. doi: 10.1016/S0001-7310(17)30002-9.
The current controversy in the setting of dermatology surrounding the treatment of inflammatory diseases, and specifically hidradenitis suppurativa, bears strong similarities with the debate concerning inflammatory bowel disease (IBD) that took place several years ago. That debate led to new perspectives on this disease and, in particular, its treatment after the development of biological agents.
目前皮肤科领域围绕炎症性疾病治疗，尤其是化脓性汗腺炎治疗的争议，与几年前关于炎症性肠病（IBD）的争论有诸多相似之处。那场争论为该疾病带来了新的观点，特别是在生物制剂研发后其治疗方面的新观点。
